MNTA - Momenta Pharmaceuticals, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow

Income Statement

Annual
All numbers in thousands
Revenue12/31/201712/31/201612/31/201512/31/2014
Total Revenue138,882109,61989,65052,250
Cost of Revenue72,46741,17352,58532,455
Gross Profit66,41568,44637,06519,795
Operating Expenses
Research Development76,75978,70773,44874,027
Selling General and Administrative82,20764,46648,05145,164
Non Recurring----
Others----
Total Operating Expenses231,433184,346174,084151,646
Operating Income or Loss-92,551-74,727-84,434-99,396
Income from Continuing Operations
Total Other Income/Expenses Net4,45553,7241,121796
Earnings Before Interest and Taxes-92,551-74,727-84,434-99,396
Interest Expense----
Income Before Tax-88,096-21,003-83,313-98,600
Income Tax Expense----
Minority Interest----
Net Income From Continuing Ops-88,096-21,003-83,313-98,600
Non-recurring Events
Discontinued Operations----
Extraordinary Items----
Effect Of Accounting Changes----
Other Items----
Net Income
Net Income-88,096-21,003-83,313-98,600
Preferred Stock And Other Adjustments----
Net Income Applicable To Common Shares-88,096-21,003-83,313-98,600